Transcription factors WT1 and p53 combined: a prognostic biomarker in ovarian cancer

被引：0
|
作者：
Julia H. Carter
James A. Deddens
Gretchen Mueller
Thomas G. Lewis
Mariah K. Dooley
Michelle C. Robillard
Molly Frydl
Lydia Duvall
Jackson O. Pemberton
Larry E. Douglass
机构：
[1] Wood Hudson Cancer Research Laboratory,Department of Mathematical Sciences
[2] University of Cincinnati,undefined
[3] St. Elizabeth Healthcare,undefined
来源：
British Journal of Cancer | 2018年 / 119卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：462 / 470
页数：8
相关论文
共 50 条
  • [1] Transcription factors WT1 and p53 combined: a prognostic biomarker in ovarian cancer
    Carter, Julia H.
    Deddens, James A.
    Mueller, Gretchen
    Lewis, Thomas G.
    Dooley, Mariah K.
    Robillard, Michelle C.
    Frydl, Molly
    Duvall, Lydia
    Pemberton, Jackson O.
    Douglass, Larry E.
    BRITISH JOURNAL OF CANCER, 2018, 119 (04) : 462 - 470
  • [2] The association of oncogenic role between WT1 and p53 in breast cancer
    Kanokwiroon, K.
    Graidist, P.
    FEBS JOURNAL, 2012, 279 : 59 - 59
  • [3] A Proposed Kinetic Model for the Diagnostic and Prognostic Value of WT1 and p53 in Acute Myeloid Leukemia
    Bani-Ahmad, Mohammad A.
    Al-Sweedan, Suleimman A.
    Al-Asseiri, Mohammad A.
    Alkhatib, Ahed J.
    CLINICAL LABORATORY, 2018, 64 (03) : 357 - 363
  • [4] PHYSICAL AND FUNCTIONAL INTERACTION BETWEEN WT1 AND P53 PROTEINS
    MAHESWARAN, S
    PARK, S
    BERNARD, A
    MORRIS, JF
    RAUSCHER, FJ
    HILL, DE
    HABER, DA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (11) : 5100 - 5104
  • [5] DIAGNOSTIC SIGNIFICANCE OF P53, P16, WT1 IN LAVAGE SAMPLES FROM UTERINE CAVITY FOR SEROUS OVARIAN CANCER DETECTION
    Zhordania, K.
    Gokadze, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A161 - A161
  • [6] p53, WT1, and PAX8 Immunohistochemical Profiles in Ovarian Malignant Mesodermal Mixed Tumors
    Sy, K.
    Cesari, M.
    Nofech-Mozes, S.
    Ghorab, Z.
    Ismiil, N.
    Dube, V.
    Khalifa, M. A.
    Han, G.
    LABORATORY INVESTIGATION, 2013, 93 : 297A - 297A
  • [7] p53,WT1, and PAX8 Immunohistochemical Profiles in Ovarian Malignant Mesodermal Mixed Tumors
    Sy, K.
    Cesari, M.
    Nofech-Mozes, S.
    Ghorab, Z.
    Ismiil, N.
    Dube, V.
    Khalifa, M. A.
    Han, G.
    MODERN PATHOLOGY, 2013, 26 : 297A - 297A
  • [8] Differential expression of WT1 and p53 in serous and endometrioid carcinomas of the endometrium
    Egan, JA
    Ionescu, MC
    Eapen, E
    Jones, JG
    Marshall, DS
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2004, 23 (02) : 119 - 122
  • [9] WT1, p53 and hormone receptor expression in uterine serous carcinoma
    Hirschowitz, Lynn
    Ganesan, Raji
    McCluggage, W. Glenn
    HISTOPATHOLOGY, 2009, 55 (04) : 478 - 482
  • [10] THE WT1 GENE-PRODUCT STABILIZES P53 AND INHIBITS P53-MEDIATED APOPTOSIS
    MAHESWARAN, S
    ENGLERT, C
    BENNETT, P
    HEINRICH, G
    HABER, DA
    GENES & DEVELOPMENT, 1995, 9 (17) : 2143 - 2156
12345